MCID: CLT003
MIFTS: 62

Colitis

Categories: Gastrointestinal diseases

Aliases & Classifications for Colitis

MalaCards integrated aliases for Colitis:

Name: Colitis 12 76 29 55 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:0060180
ICD10 33 K52.9
MeSH 44 D003092
NCIt 50 C26723
SNOMED-CT 68 64226004
UMLS 73 C0009319

Summaries for Colitis

Disease Ontology : 12 An inflammatory bowel disease that involves inflammation located in colon.

MalaCards based summary : Colitis is related to microscopic colitis and crohn's colitis. An important gene associated with Colitis is NOD2 (Nucleotide Binding Oligomerization Domain Containing 2), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Azathioprine and Hydrocortisone have been mentioned in the context of this disorder. Affiliated tissues include colon, colon and t cells, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

Wikipedia : 76 Colitis is an inflammation of the colon. Colitis may be acute and self-limited or long-term. It broadly... more...

Related Diseases for Colitis

Diseases related to Colitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 814)
# Related Disease Score Top Affiliating Genes
1 microscopic colitis 34.5 IFNG IL2 IL6 TNF
2 crohn's colitis 34.0 CXCL8 IFNG IL1B IL2 NOD2 TNF
3 pouchitis 33.6 CXCL8 IL10 NOD2
4 inflammatory bowel disease 25, autosomal recessive 33.5 IL10 IL10RA IL10RB
5 pyoderma gangrenosum 33.4 CXCL8 NOD2 TNF
6 irritable bowel syndrome 32.6 IL10 TLR9 TNF
7 ileocolitis 32.5 MYO9B NOD2 TNF
8 gastroenteritis 32.4 CXCL8 IFNG IL10 IL1B IL6 TNF
9 ulcerative colitis 32.1 ABCB1 ATG16L1 CTNNB1 CXCL8 IL10 IL10RA
10 pyoderma 32.0 CXCL8 NOD2 TNF
11 ileitis 31.7 IL17A IL6 MPO NOD2 TNF
12 celiac disease 1 31.1 IFNG IL10 IL2 MYO9B TNF
13 crohn's disease 31.0 ABCB1 ATG16L1 IL10 IL10RA IL10RB IL1B
14 trichuriasis 30.8 CXCL8 IL10 TNF
15 spondyloarthropathy 1 30.8 IL17A NOD2 TNF
16 familial mediterranean fever 30.8 IL1B NOD2 TNF
17 autoimmune inner ear disease 30.7 MPO TNF
18 fasciitis 30.7 CXCL8 IL6 TNF
19 esophagitis 30.7 CXCL8 IL1B IL6
20 cytomegalovirus infection 30.7 CXCL8 IFNG IL10 IL6 TNF
21 peptic ulcer disease 30.5 CXCL8 IL10 IL1B TNF
22 wells syndrome 30.5 CXCL8 IL1B IL2
23 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 30.5 IFNG IL10 IL17A
24 pericarditis 30.5 IL1B IL6 TNF
25 acute pancreatitis 30.5 CXCL8 IL10 IL6 MPO
26 erythema multiforme 30.5 IFNG IL2 TNF
27 reactive arthritis 30.5 IFNG IL10 IL6 TNF
28 cystitis 30.5 CXCL8 IL6 TNF
29 anca-associated vasculitis 30.4 IL6 MPO TNF
30 bronchitis 30.4 CXCL8 MPO TNF
31 hidradenitis suppurativa 30.4 IL17A NOD2 TNF
32 hidradenitis 30.4 IL17A NOD2 TNF
33 myelitis 30.4 IL17A IL6 TNF
34 pleurisy 30.4 CXCL8 IFNG IL2 MPO TNF
35 spondylitis 30.3 IL17A IL23R IL6 NOD2 TNF
36 appendicitis 30.3 CXCL8 IL10 IL1B IL6 MPO TNF
37 peritonitis 30.3 CXCL8 IL10 IL1B IL6 MPO TNF
38 granulomatous dermatitis 30.3 NOD2 TNF
39 pulmonary sarcoidosis 30.3 IFNG IL2 TNF
40 necrotizing fasciitis 30.3 CXCL8 IL2 IL6
41 chronic granulomatous disease 30.3 IFNG IL1B MPO TLR9 TNF
42 uveitis 30.3 IFNG IL10 IL17A NOD2 TNF
43 listeriosis 30.3 IL10 IL6 TNF
44 hematopoietic stem cell transplantation 30.3 IFNG IL10 IL2 IL6 TNF
45 herpes zoster 30.3 IFNG IL10 IL2
46 helicobacter pylori infection 30.2 CXCL8 IFNG IL10 IL1B TNF
47 fascioliasis 30.2 IFNG IL10 IL1B
48 neuritis 30.2 IFNG IL1B TNF
49 alopecia areata 30.2 IFNG IL2 TNF
50 obstructive jaundice 30.2 CXCL8 IL6 TNF

Graphical network of the top 20 diseases related to Colitis:



Diseases related to Colitis

Symptoms & Phenotypes for Colitis

GenomeRNAi Phenotypes related to Colitis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.88 IL17A IL1B IL2 MPO MYO9B NOD2
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.88 IL17A IL1B IL2 MPO MYO9B NOD2

MGI Mouse Phenotypes related to Colitis:

46 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.39 MUC2 IL10 CTNNB1 MYO9B NOD2 ABCB1
2 digestive/alimentary MP:0005381 10.37 MUC2 IL10 CTNNB1 NOD2 ABCB1 IFNG
3 homeostasis/metabolism MP:0005376 10.33 TNF MUC2 IL10 CTNNB1 IL6 NOD2
4 cellular MP:0005384 10.32 ATG16L1 TNF MUC2 IL10 MYO9B CTNNB1
5 immune system MP:0005387 10.32 MUC2 IL10 CTNNB1 MYO9B IL6 NOD2
6 growth/size/body region MP:0005378 10.3 ATG16L1 TNF MUC2 IL10 CTNNB1 NOD2
7 cardiovascular system MP:0005385 10.26 ATG16L1 TNF MUC2 IL10 CTNNB1 IL6
8 endocrine/exocrine gland MP:0005379 10.26 TNF MUC2 IL10 CTNNB1 IL6 ABCB1
9 mortality/aging MP:0010768 10.13 ATG16L1 TNF MUC2 IL10 CTNNB1 NOD2
10 liver/biliary system MP:0005370 9.92 TNF IL10 CTNNB1 IL6 ABCB1 IFNG
11 neoplasm MP:0002006 9.81 TNF MUC2 IL10 CTNNB1 IL6 IFNG
12 no phenotypic analysis MP:0003012 9.56 IFNG TNF CTNNB1 ABCB1 IL17A IL23R
13 respiratory system MP:0005388 9.23 IFNG TNF CTNNB1 IL6 IL17A IL10

Drugs & Therapeutics for Colitis

Drugs for Colitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 422)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azathioprine Approved Phase 4,Phase 3,Phase 2,Not Applicable 446-86-6 2265
2
Hydrocortisone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 50-23-7 5754
3
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 170277-31-3
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
5
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
6
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 331731-18-1 16219006
7
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
8 Vedolizumab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 943609-66-3
9
Aminosalicylic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 65-49-6 4649
10
Vancomycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1404-90-6 441141 14969
11
Loperamide Approved Phase 4,Phase 3,Phase 2,Not Applicable 53179-11-6 3955
12
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 85721-33-1 2764
13
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2 22916-47-8 4189
14
Benzocaine Approved, Investigational Phase 4,Phase 3,Not Applicable 1994-09-7, 94-09-7 2337
15
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
16
Menthol Approved Phase 4,Phase 2,Not Applicable 2216-51-5 16666
17
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 53-03-2 5865
18
Rifaximin Approved, Investigational Phase 4,Not Applicable 80621-81-4 6436173
19
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
20
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
21
Cefazolin Approved Phase 4,Phase 2,Phase 3,Not Applicable 25953-19-9 656510 33255
22
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
23
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Not Applicable 26787-78-0 33613
24
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 564-25-0 54671203
25
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 443-48-1 4173
26
Nicotine Approved Phase 4 54-11-5 942 89594
27
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable 93-14-1 3516
28
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 73590-58-6 4594
29
Sulfamethoxazole Approved Phase 4,Not Applicable 723-46-6 5329
30
Trimethoprim Approved, Vet_approved Phase 4,Not Applicable 738-70-5 5578
31
Methotrexate Approved Phase 4,Phase 2,Not Applicable 1959-05-2, 59-05-2 126941
32
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
33
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
34
Losartan Approved Phase 4 114798-26-4 3961
35
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
36
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
37
Copper Approved, Investigational Phase 4 7440-50-8 27099
38
Zinc Approved, Investigational Phase 4 7440-66-6 23994
39
Ceftriaxone Approved Phase 4,Phase 2 73384-59-5 5479530 5361919
40
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
41
Ofloxacin Approved Phase 4 82419-36-1 4583
42
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
43
Nitrofurantoin Approved, Vet_approved Phase 4,Not Applicable 67-20-9 5353830
44
Thioguanine Approved Phase 4 154-42-7 2723601
45
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
46
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
47 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Not Applicable
48
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 59-30-3 6037
49
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Not Applicable 58-05-9 143 6006
50
Vitamin C Approved, Nutraceutical Phase 4,Not Applicable 50-81-7 5785 54670067

Interventional clinical trials:

(show top 50) (show all 1203)
# Name Status NCT ID Phase Drugs
1 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
2 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
3 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
4 Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe Unknown status NCT01630096 Phase 4 Nu-Lytely
5 A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis Unknown status NCT02425852 Phase 4 Azathioprine;Infliximab;Prednisolone;Hydrocortisone
6 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
7 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
8 Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab Unknown status NCT02453776 Phase 4 PRECISION dosing Infliximab
9 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Unknown status NCT01632462 Phase 4 VSL#3
10 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
11 Manipulation of Visceral Sensitivity and Immune System in IBS Unknown status NCT00418340 Phase 4 probiotic (bacterial/dietary supplement)
12 Pain Relief In Irritable Bowel Syndrome Unknown status NCT02573844 Phase 4 Proklama
13 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
14 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
15 Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) Completed NCT02092285 Phase 4 Golimumab
16 Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle Completed NCT01772615 Phase 4 Ciprofloxacin
17 Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis Completed NCT01408810 Phase 4 Infliximab
18 Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) Completed NCT02155335 Phase 4 Prefilled Syringe delivery of Golimumab;Smartject Device delivery of Golimumab
19 Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) Completed NCT00446849 Phase 4 MMX Mesalamine
20 Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis Completed NCT01201122 Phase 4 Mesalamine
21 Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis Completed NCT00542152 Phase 4 CYCLOSPORINE VS INFLIXIMAB
22 Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis Completed NCT01124149 Phase 4 MMX mesalamine/ mesalazine
23 Asacol Dosing Study for Active Ulcerative Colitis Completed NCT00194818 Phase 4 Asacol (mesalamine)
24 Adacolumn in Refractory UC Patients Trial Completed NCT01481142 Phase 4
25 Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). Completed NCT02318667 Phase 4
26 Dose Escalation and Remission (DEAR) Completed NCT00652145 Phase 4 mesalamine
27 Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) Completed NCT00219414 Phase 4
28 The NOR-SWITCH Study Completed NCT02148640 Phase 4 Innovator infliximab;Biosimilar infliximab
29 Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis Completed NCT01418131 Phase 4 Rectal tacrolimus;Placebo
30 Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) Completed NCT01346826 Phase 4 Standard 2 hours-infusion;Accelerated 1 hour-infusion;Accelerated 30 minutes-infusion
31 Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate Completed NCT01991314 Phase 4 Ferrous sulphate
32 Low Volume Colon Preparation for IBD Completed NCT02248337 Phase 4 Colon preparation for colonoscopy
33 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease Completed NCT01908283 Phase 4
34 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Completed NCT02246361 Phase 4
35 Single-dose Linaclotide for Capsule Endoscopy Preparation Completed NCT02465385 Phase 4 Linaclotide
36 The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels Completed NCT00167882 Phase 4 5-aminosalicylate (Pentasa, Ferring)
37 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Completed NCT01341808 Phase 4
38 Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease Completed NCT01981889 Phase 4 Prednisone
39 Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea Completed NCT01670149 Phase 4 Rifaximin;Placebo
40 Efficacy Study of Pneumococcal Vaccination in Crohn's Disease Completed NCT01505855 Phase 4 23-valent polysaccharide pneumococcal vaccine
41 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Completed NCT01174186 Phase 4 Adalimumab
42 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
43 A Trial of Iron Replacement in Patients With Iron Deficiency. Completed NCT01067547 Phase 4 Iron Sucrose.;Iron sucrose
44 Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Completed NCT02162862 Phase 4 bupropion-SR
45 Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction Completed NCT01244698 Phase 4 Cefadroxil discontinued early;Cefadroxil until drain removal
46 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Completed NCT01668004 Phase 4
47 Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix TM) Administered in Healthy Adolescents Completed NCT00534638 Phase 4
48 Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis Recruiting NCT02345733 Phase 4 Antibiotic cocktail
49 Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis Recruiting NCT02770040 Phase 4 Infliximab
50 Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis Recruiting NCT02687724 Phase 4 Golimumab (GLM)

Search NIH Clinical Center for Colitis

Cochrane evidence based reviews: colitis

Genetic Tests for Colitis

Genetic tests related to Colitis:

# Genetic test Affiliating Genes
1 Colitis 29

Anatomical Context for Colitis

The Foundational Model of Anatomy Ontology organs/tissues related to Colitis:

19
Colon

MalaCards organs/tissues related to Colitis:

41
Colon, T Cells, Neutrophil, Testes, Bone, Liver, Monocytes

Publications for Colitis

Articles related to Colitis:

(show top 50) (show all 5031)
# Title Authors Year
1
Decreased risk for microscopic colitis and inflammatory bowel disease among patients with reflux disease. ( 29603881 )
2018
2
Hypoxia-inducible factor-1 (HIF-1) activation in myeloid cells accelerates DSS-induced colitis progression in mice. ( 29967068 )
2018
3
Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFI+ treatment in chronic DSS-induced colitis. ( 29967942 )
2018
4
Microscopic colitis-microbiome, barrier function and associated diseases. ( 29610731 )
2018
5
Chemical colitis caused by hydrogen peroxide enema in a child: case report and literature review. ( 29631344 )
2018
6
How Common-and How Serious- Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset. ( 29443839 )
2018
7
Microscopic colitis in Denmark and Sweden: incidence, putative risk factors, histological assessment and endoscopic activity. ( 29852792 )
2018
8
C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. ( 29420262 )
2018
9
Ischemic Colitis in Sickle Cell Disease: A Case Report of a Diagnostic Challenge. ( 29623225 )
2018
10
Editor's Spotlight/Take 5: How Common-and How Serious-Is Clostridium difficile Colitis After Geriatric Hip Fracture? Findings from the NSQIP Dataset. ( 29443838 )
2018
11
Histone Acetyltransferase Mof Affects the Progression of DSS-Induced Colitis. ( 29975939 )
2018
12
Evaluation by MR Enterocolonography of Lansoprazole-induced Collagenous Colitis Accompanied with Protein-losing Enteropathy. ( 29033425 )
2018
13
A Case of Pulmonary Alveolar Proteinosis with Ulcerative Colitis. ( 29709938 )
2018
14
5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis. ( 29951050 )
2018
15
Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis. ( 29435325 )
2018
16
Peyer's patches-derived CD11b<sup>+</sup> B cells recruit regulatory T cells through CXCL9 in DSS-induced colitis. ( 29969845 )
2018
17
Long-Term Outcomes of Immunosuppression-NaA^ve Steroid Responders Following Hospitalization for Ulcerative Colitis. ( 29951797 )
2018
18
Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis. ( 29450747 )
2018
19
Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. ( 29370359 )
2018
20
The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis. ( 29968483 )
2018
21
Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-I_B/MAPKs Pathway. ( 29959727 )
2018
22
The Therapeutic Effects of Adipose-Derived Stem Cells and Recombinant Peptide Pieces on Mouse Model of DSS Colitis. ( 29978718 )
2018
23
Frailty Predicts Morbidity and Mortality after Colectomy for Clostridium difficile Colitis. ( 29966560 )
2018
24
Ischemic colitis following left antegrade sclerotherapy for idiopathic varicocele. ( 29473213 )
2018
25
Gas In The Hepatic Portal Venous System Associated With Ischemic Colitis. ( 29880969 )
2018
26
Regulation of JAK2/STAT3 and NF-I_B signal transduction pathways; Veronica polita alleviates dextran sulfate sodium-induced murine colitis. ( 29448206 )
2018
27
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review. ( 29968984 )
2018
28
The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis. ( 29941222 )
2018
29
T-Bet Is Dependent on Stat-4 Inhibiting Acute Colitis but Not Stat-1 Using L4 Somatic Antigen of <i>Heligmosomoides polygyrus</i>. ( 29977172 )
2018
30
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis. ( 29928204 )
2018
31
Alterations in melatonin and serotonin signalling in the colonic mucosa of mice with dextran-sodium sulfate-induced colitis. ( 29447434 )
2018
32
The subtypes of microscopic colitis from a pathologist's perspective: past, present and future. ( 29610757 )
2018
33
New perspectives on the long-term outcome of segmental colectomy for Crohn's colitis: an observational study on 200 patients. ( 29511841 )
2018
34
Microscopic colitis: a population-based case series over a 9-year period in Northern Ireland. ( 29742325 )
2018
35
Pembrolizumab-Induced Microscopic Colitis. ( 29610496 )
2018
36
Paediatric<i>Clostridium difficile</i>pseudomembranous colitis: a complication of refractory constipation? ( 29444797 )
2018
37
Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis. ( 29607962 )
2018
38
Fresh Fruit Juice of Opuntia dillenii Haw. Attenuates Acetic Acid-Induced Ulcerative Colitis in Rats. ( 29958056 )
2018
39
Clozapine Associated With Microscopic Colitis in the Setting of Biopsy-Proven Celiac Disease. ( 29424803 )
2018
40
Cytomegalovirus Infection in Pediatric Severe Ulcerative Colitis-A Multicenter Study from the Pediatric Inflammatory Bowel Disease Porto Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. ( 29424814 )
2018
41
Pyoderma Gangrenosum of the Preauricular Area with Ulcerative Colitis: A Case Report and Review. ( 29890815 )
2018
42
A case report of successful management of clostridium difficile colitis with antegrade Fidaxomicin through a mucous fistula obviating the need for subtotal colectomy. ( 29227855 )
2018
43
What Is the Risk of Progressive Multifocal Leukoencephalopathy in Patients With Ulcerative Colitis or Crohn's Disease Treated With Vedolizumab? ( 29668955 )
2018
44
Pyoderma gangrenosum with its subtype affecting oral mucosa pyostomatitis vegetans following skin melanoma surgical excision in a patient with ulcerative colitis: a case report. ( 29760625 )
2018
45
Magnesium poisoning, multi-organ failure and ischemic colitis secondary to chronic ingestion of a parapharmacy product. ( 29667416 )
2018
46
Genomic characterization of colitis-associated colorectal cancer. ( 29966533 )
2018
47
<i>Clostridium difficile</i> Colitis Leading to Reactive Arthritis: A Rare Complication Associated With a Common Disease. ( 29623279 )
2018
48
An Overview of Molecular Profiles in Ulcerative Colitis-Related Cancer. ( 29945208 )
2018
49
Ileal pouch of ulcerative colitis and familial adenomatous polyposis patients exhibit modulation of autophagy markers. ( 29422639 )
2018
50
Enteric Delivery of Regenerating Family Member 3 alpha AltersA the Intestinal Microbiota and Controls Inflammation inA Mice WithA Colitis. ( 29133078 )
2018